| 生物活性 | |||
|---|---|---|---|
| 描述 | ARS-853 is a selective, covalent inhibitor of KRAS G12C, featuring an IC50 of 2.5 μM. By attaching to the GDP-bound form of the mutant KRAS oncoprotein, ARS-853 blocks its activation, thereby inhibiting KRAS-driven signaling pathways[1].[2]. | ||
| 作用机制 | ARS-853 covalently inhibits KRAS G12C and targets the GDP-bound, inactives state and prevents subsequent activation.[1][2] | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 
                         1 mM 5 mM 10 mM  | 
                    
						 2.31mL 0.46mL 0.23mL  | 
                    
						 11.55mL 2.31mL 1.15mL  | 
                    
						 23.10mL 4.62mL 2.31mL  | 
                
| 参考文献 | 
|---|